Geisinger Clinic
geisinger.orgTotal trials
120
Active
17
Phase 3
1
Total enrollment
1,395,345
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 9 of 9 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Colchicine 1.8 mg (loading dose) + Dextrose Oral Placebo | — | — | — | — | — | 1 | |
| Colchicine 1.8 mg + 0.6 mg | — | — | — | — | — | 1 | |
| Dextrose Oral Placebo | — | — | — | — | — | 1 | |
| mineral trioxide aggregate | — | — | — | — | — | 1 | |
| Topical Timolol | — | — | — | — | — | 1 | |
| Normal Saline | — | — | — | — | — | 1 | |
| Amoxicillin | — | — | — | — | — | 1 | |
| Liposomal bupivacaine | — | — | — | — | 2 | ||
| Multigene pharmacogenomics test | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
- 2025-12-31
- 2026-01-01
- 2026-06
- 2026-08-01
- 2028-07
Top conditions
- Obesity10
- Health Promotion8
- Health Behavior6
- Influenza5
- Emergency Service, Hospital4
- Hypertension4
- Telehealth3
- Behavioral Intervention3
Frequently asked questions about Geisinger Clinic
- How many clinical trials does Geisinger Clinic have on ClinicalTrials.gov?
- Geisinger Clinic is listed as the lead sponsor on 120 clinical trials in ClinicalTrials.gov, 17 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Geisinger Clinic's trials are in Phase 3?
- 1 of Geisinger Clinic's trials are in Phase 3, spread across 9 active drug programs.
- What therapeutic areas does Geisinger Clinic focus on?
- Geisinger Clinic's most-studied conditions on ClinicalTrials.gov are Obesity, Health Promotion, Health Behavior, Influenza, Emergency Service, Hospital.
- When are Geisinger Clinic's next clinical trial readouts?
- Geisinger Clinic has 6 upcoming primary-completion readouts tracked here; the soonest is “Geisinger Antibiotic Allergy Pilot Program: Assess and Address”, expected around 2025-12-31.